Concepedia
Statistics
Publications
1
Citations
21
H-Index
Active since
2021
Affiliations
Chulalongkorn University(Current)
Istvan Abert is an author at Chulalongkorn University.
Publications per year
2021–2021
Efficacy and Safety of Bevacizumab Biosimilar FKB238 Versus Originator Bevacizumab: Results from AVANA, a Phase III Trial in Patients with Non-Squamous Non-Small-Cell Lung Cancer (non-sq-NSCLC)
Konstantinos Syrigos, Istvan Abert, Zoran Andric et al. · BioDrugs · 2021 · 21 citations · Full text
1–1 of 1